Concepedia

Palifermin Use

Palifermin Use is a clinical intervention strategy involving the administration of recombinant human keratinocyte growth factor to mitigate the severity and duration of oral mucositis in patients undergoing high-dose chemotherapy or radiation therapy, particularly in the context of hematopoietic stem cell transplantation.

66

Publications

4.8K

Citations

390

Authors

176

Institutions

Publications per year

2017–2026

2

Parents

Publications

66

Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers

Ricardo Spielberger, Patrick J. Stiff, William Bensinger et al. · New England Journal of Medicine · 2004 · 901 citations

, , +15

Updated clinical practice guidelines for the prevention and treatment of mucositis

Dorothy Keefe, Mark M. Schubert, Linda S. Elting et al. · Cancer · 2007 · 784 citations

, , +17

NCCN Task Force Report: Prevention and Management of Mucositis in Cancer Care

William Bensinger, Mark Schubert, Kie-Kian Ang et al. · Journal of the National Comprehensive Cancer Network · 2008 · 242 citations · Full text

, , +15

Palifermin Reduces Severe Mucositis in Definitive Chemoradiotherapy of Locally Advanced Head and Neck Cancer: A Randomized, Placebo-Controlled Study

Quynh‐Thu Le, Harold E. Kim, Charles Schneider et al. · Journal of Clinical Oncology · 2011 · 186 citations

, , +15

Clinical and economic consequences of mucositis induced by chemotherapy and/or radiation therapy.

Sol Silverman · PubMed · 2007 · 180 citations

, , +17

1–5 of 66

Authors

390

  1. RS
    Ricardo Spielberger

    City Of Hope National Medical Center, United States

    6 publications · 1.4K citations

    6

    h-index

  2. PJ
    Patrick J. Stiff

    Loyola University Medical Center, United States

    5 publications · 1.1K citations

    5

    h-index

  3. DB
    Dietmar Berger

    University of Freiburg, Germany

    4 publications · 472 citations

    4

    h-index

  4. WB
    William Bensinger

    Fred Hutch Cancer Center, United States

    4 publications · 1.4K citations

    4

    h-index

  5. WD
    Wolfgang Dörr

    University Hospital Carl Gustav Carus, Germany

    4 publications · 122 citations

    4

    h-index

1–5 of 390

Institutions

176

  1. Amgen (United States)

    Thousand Oaks, United States

    11 h-index

    48 publications

    5.4K citations

  2. Swedish Orphan Biovitrum (Sweden)

    Stockholm, Sweden

    5 h-index

    14 publications

    270 citations

  3. University Hospital Carl Gustav Carus

    Dresden, Germany

    5 h-index

    9 publications

    336 citations

  4. City Of Hope National Medical Center

    Duarte, United States

    4 h-index

    19 publications

    2.6K citations

  5. Radboud University Medical Center

    Nijmegen, The Netherlands

    4 h-index

    10 publications

    240 citations

  6. Radboud University Nijmegen

    Nijmegen, The Netherlands

    4 h-index

    10 publications

    240 citations

  7. University of Minnesota

    Minneapolis, United States

    3 h-index

    12 publications

    3K citations

  8. Klinik und Poliklinik für Strahlentherapie und Radioonkologie

    Munich, Germany

    3 h-index

    8 publications

    238 citations

1–8 of 176

Venues

  1. Biology of Blood and Marrow Transplantation

    TCT · 7 publications · 222 citations

    7

    h-index

  2. Bone Marrow Transplantation

    6 publications · 229 citations

    6

    h-index

  3. PubMed

    Repository · 6 publications · 313 citations

    6

    h-index

  4. Journal of Clinical Oncology

    5 publications · 716 citations

    5

    h-index

  5. Supportive Care in Cancer

    3 publications · 91 citations

    3

    h-index

1–5